Rising Use-Case Of Carglumic Acid As An Orphan Drug Is Poised To Uphold

Carglumic acid, also known as N-carbamyl-L-glutamic acid, is an amino acid derivative used for the treatment of hyperammonemia, a condition characterized by elevated levels of ammonia in the blood. Hyperammonemia can be caused by genetic disorders, liver disease, or other metabolic disorders. The market for carglumic acid is driven by the increasing prevalence of hyperammonemia and the growing demand for effective treatments. Carglumic acid works by enhancing the activity of the enzyme N-acetylglutamate synthase, which plays a key role in the urea cycle, a process that helps remove ammonia from the body. As a result, carglumic acid can help reduce ammonia levels in patients with hyperammonemia and prevent complications associated with the condition.

The carglumic acid market is primarily dominated by a few key players, including Recordati Rare Diseases Inc. and Orphan Europe. These companies have developed and marketed drugs containing carglumic acid, such as Carbaglu and N-Carbamylglutamate. The market for carglumic acid is also driven by increasing investment in research and development by pharmaceutical companies and academic institutions. Researchers are exploring the potential of carglumic acid in treating other conditions, such as Parkinson’s disease, and studying its mechanism of action and safety profile.

Overall, the carglumic acid market is expected to grow in the coming years as the demand for effective treatments for hyperammonemia continues to increase, and as more research is conducted to explore the potential of carglumic acid in treating other conditions.

Download Free Sample Copy of this Report:

Key findings of the Carglumic Acid market study:

  • The report provides a present market outlook on Carglumic Acid. Additionally, the Carglumic Acid market share is anticipated to grow with a CAGR of 7.5% in the forecast period.
  • Regional breakdown of the Carglumic Acid market based on predefined taxonomy.
  • Innovative manufacturing processes implemented by Carglumic Acid vendors in detail.
  • Region-wise and country-wise fragmentation of the Carglumic Acid market to grasp the revenue, and growth outlook in these areas.
  • Changing preferences among consumers across various regions and countries.
  • Factors (Positive and Negative) impacting the growth of the global Carglumic Acid market.
  • Carglumic Acid price, market share, and Trends forecast for assessment period 2021-2031

Competitive landscape analysis

The market survey conducted by offers key developments and challenges affecting the pharmaceutical industry, subsequently influencing demand and sales in the Carglumic Acid market. To study competitive trends across the industry, the report profiles some of the leading players operating in the Carglumic Acid market including

  • Apothecon Pharmaceuticals Pvt. Ltd
  • Manus Aktteva Biopharma LLP
  • Civentichem LLC
  • Dipharma Francis S.r.I
  • Recordati Rare Diseases

Report benefits & key questions answered

  • Carglumic Acid historical market outlook: the market intelligence survey report discloses the demand and sales projections of Carglumic Acid over the last forecast period 2016 to 2020.
  • Post impact of covid on the Carglumic Acid market: the pharmaceutical industry has been largely influenced by covid-19 pandemic. The market survey assesses how current trends that will influence expenditure on Carglumic Acid, thus affecting the market growth.
  • Carglumic Acid market trend analysis: the report provides in-depth overview of the past, recent, and upcoming trends in the Carglumic Acid market to assist the businesses to formulate their strategies for expansion.
  • Carglumic Acid category & segment level analysis:’s category & segment level analysis provides insights into Carglumic Acid sales outlook on lucrative and nascent product types. The report assists the market players to identify potential remunerative segments and set sales targets at local, country, and regional level.
  • Carglumic Acid company & brand share analysis: the report discloses the competitiveness of the Carglumic Acid market and highlights the market share captured by tier 1, tier 2, and tier 3 players operating in the landscape.

Key Segments Covered in Carglumic Acid Industry Survey

·         By Dosage

    • Dispersible Tablets
    • Orally Disintegrating Tablets
    • Others

·         By Distribution Channel

    • Hospital Pharmacies
    • Retail Pharmacies
    • e-Commerce